Fighting the Antibiotic Crisis: Flavonoids as Promising Antibacterial Drugs Against Helicobacter pylori Infection
Authors:
Open Access
- 20 July 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 11
Abstract
Over half of the world’s population is estimated to be infected with Helicobacter pylori. Chronic infection with this microbial class I carcinogen is considered the most important risk factor for developing gastric cancer. The increasing antimicrobial resistance to first-line antibiotics mainly causes the failure of current eradication therapies, inducing refractory infections. The alarming increase in multidrug resistance in H. pylori isolates worldwide is already beginning to limit the efficacy of existing treatments. Consequently, the World Health Organization (WHO) has included H. pylori in its list of “priority pathogens” for which new antibiotics are urgently needed. Novel strategies must be followed to fight this antibiotic crisis, including properly exploiting the proven therapeutic potential of medicinal plants and plant-derived phytochemicals. In this mini-review, we overview the impressive properties of naturally occurring flavonoids as effective antimicrobial agents against H. pylori, which support the use of these plant-derived bioactive compounds as promising drug candidates for inclusion in novel and personalized combinatory therapies against H. pylori infection.Keywords
Funding Information
- Universidad de Zaragoza
- Gobierno de Aragón
This publication has 100 references indexed in Scilit:
- Antimicrobial Effect of 7-O-Butylnaringenin, a Novel Flavonoid, and Various Natural Flavonoids against Helicobacter pylori StrainsInternational Journal of Environmental Research and Public Health, 2013
- Flavonoid Bioavailability and Attempts for Bioavailability EnhancementNutrients, 2013
- Antibacterial activities of almond skins on cagA-positive and-negative clinical isolates of Helicobacter pyloriBMC Microbiology, 2013
- Mutations to Essential Orphan Response Regulator HP1043 of Helicobacter pylori Result in Growth-Stage Regulatory DefectsInfection and Immunity, 2013
- Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesisFrontiers in Cellular and Infection Microbiology, 2012
- Aqueous and Organic Solvent-Extracts of Selected South African Medicinal Plants Possess Antimicrobial Activity against Drug-Resistant Strains of Helicobacter pylori: Inhibitory and Bactericidal PotentialInternational Journal of Molecular Sciences, 2011
- Mechanisms of disease: Helicobacter pylori virulence factorsNature Reviews Gastroenterology & Hepatology, 2010
- Bioavailability of the Polyphenols: Status and ControversiesInternational Journal of Molecular Sciences, 2010
- Three flavonoids targeting the β‐hydroxyacyl‐acyl carrier protein dehydratase from Helicobacter pylori: Crystal structure characterization with enzymatic inhibition assayProtein Science, 2008
- Pathogenesis ofHelicobacter pyloriInfectionClinical Microbiology Reviews, 2006